Targeted healthcare Small team with a focus on medical devices and surface pattern technology presents a niche opportunity to sell specialized Sharklet coatings or embedded patterns to manufacturers of catheters, implants, and device housings seeking anti-biofilm solutions.

Non-toxic innovation Sharklet’s pattern-based, chemical- and antibiotic-free approach aligns with demand for safer, antimicrobial strategies, making it a compelling upsell to hospitals and device makers prioritizing regulatory-friendly, non-toxic surface treatments.

Global validation Recent recognition as an Innovative Medical Device in China strengthens credibility for international expansion and partnerships with Asian medical device manufacturers and distributors seeking validated anti-biofilm technologies.

Strategic partnerships Existing collaboration with a Chinese medical device firm for clinical testing signals openness to co-development and licensing deals; leverage for joint ventures, technology licensing, or pilot programs with other regional manufacturers.

Funding and traction Revenue under one million with modest funding indicates a high-growth potential target for early-stage investors or grant programs, while sales opportunities include incremental licensing, tooling, or contract R&D collaborations to scale production.